Search Results
You are looking at 1 - 1 of 1 items for
- Author: Lidia Ruiz-Llorente x
- Refine by access: All content x
Search for other papers by Verónica García-Carpizo in
Google Scholar
PubMed
Search for other papers by Lidia Ruiz-Llorente in
Google Scholar
PubMed
Instituto de Investigaciones Biomédicas, Centro Nacional de Biotecnología, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, Arturo Duperier 4, 28029 Madrid, Spain
Search for other papers by Mario Fraga in
Google Scholar
PubMed
Search for other papers by Ana Aranda in
Google Scholar
PubMed
DNA methylation is the best studied epigenetic factor, playing a key role in producing stable changes in gene expression, thus defining cell identity and function and adapting cells to environmental changes. DNA methylation has also been recently shown to mediate cell responses to physiological endocrine signals. Moreover, alterations of the normal DNA methylation pattern can also contribute to the development of endocrine and metabolic diseases and can explain the relationship between an individual's genetic background, the environment, and disease. It should be remarked that although DNA methylation and demethylation are active processes, epigenetic changes produced during development can impact adult processes, establishing the idea that endocrine function can be persistently affected by events occurring in early life. Given the complexity of the endocrine system, both genetic and epigenetic processes, including DNA methylation, must be involved in its proper development and functioning. In this study, we summarize the recent knowledge in the field of DNA methylation and endocrinology. Given that DNA methylation can be involved in a number of endocrine and metabolic disorders, understanding and manipulating this modification opens a new door for preventing and treating endocrine diseases.
